TY - JOUR AU - Te, H. S. AU - Jensen, D. M. PY - 2010 DA - 2010// TI - Epidemiology of hepatitis B and C viruses: a global overview JO - Clin Liver Dis VL - 14 UR - https://doi.org/10.1016/j.cld.2009.11.009 DO - 10.1016/j.cld.2009.11.009 ID - Te2010 ER - TY - STD TI - PubChem (2018), https://pubchem.ncbi.nlm.nih.gov/compound/Velpatasvir#section=Top. Accessed 12 Feb 2018 UR - https://pubchem.ncbi.nlm.nih.gov/compound/Velpatasvir#section%3dTop ID - ref2 ER - TY - STD TI - Wikipedia (2018) https://en.wikipedia.org/wiki/Sofosbuvir. Accessed 12 Feb 2018 UR - https://en.wikipedia.org/wiki/Sofosbuvir ID - ref3 ER - TY - STD TI - Epclusa: Uses, dosage, side effects & warnings—Drugs.com. https://www.drugs.com/epclusa.html. Accessed 3 Feb 2019 UR - https://www.drugs.com/epclusa.html ID - ref4 ER - TY - STD TI - Abdel-Gawad SA-N. Simple chromatographic and spectrophotometric determination of sofosbuvir in pure and tablet forms. Eur J Chem. 2016;7(3):375–9. http://www.eurjchem.com/index.php/eurjchem/article/view/1439. Accessed 3 Feb 2019 UR - http://www.eurjchem.com/index.php/eurjchem/article/view/1439 ID - ref5 ER - TY - JOUR AU - Miraghaei, S. AU - Mohammadi, B. AU - Babaei, A. AU - Keshavarz, S. AU - Bahrami, G. PY - 2017 DA - 2017// TI - Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC–MS/MS technique: application to a bioequivalence study JO - J Chromatogr B VL - 1063 UR - https://doi.org/10.1016/j.jchromb.2017.06.047 DO - 10.1016/j.jchromb.2017.06.047 ID - Miraghaei2017 ER - TY - JOUR AU - Nebsen, M. AU - Elzanfaly, E. S. PY - 2016 DA - 2016// TI - Stability-indicating method and LC–MS-MS characterization of forced degradation products of sofosbuvir JO - J Chromatogr Sci VL - 54 UR - https://doi.org/10.1093/chromsci/bmw119 DO - 10.1093/chromsci/bmw119 ID - Nebsen2016 ER - TY - JOUR AU - Shi, X. AU - Zhu, D. AU - Lou, J. AU - Zhu, B. AU - Hu, A. AU - Gan, D. PY - 2015 DA - 2015// TI - Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS JO - J Chromatogr B VL - 1002 UR - https://doi.org/10.1016/j.jchromb.2015.08.038 DO - 10.1016/j.jchromb.2015.08.038 ID - Shi2015 ER - TY - JOUR AU - Pan, C. AU - Chen, Y. AU - Chen, W. AU - Zhou, G. AU - Jin, L. AU - Zheng, Y. PY - 2016 DA - 2016// TI - Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study JO - J Chromatogr B Analyt Technol Biomed Life Sci. VL - 1008 UR - https://doi.org/10.1016/j.jchromb.2015.11.056 DO - 10.1016/j.jchromb.2015.11.056 ID - Pan2016 ER - TY - JOUR AU - Rezk, M. R. AU - Basalious, E. B. AU - Karim, I. A. PY - 2015 DA - 2015// TI - Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: application to a bioequivalence study JO - J Pharm Biomed Anal VL - 114 UR - https://doi.org/10.1016/j.jpba.2015.05.006 DO - 10.1016/j.jpba.2015.05.006 ID - Rezk2015 ER - TY - STD TI - Uppalapati.Jyothi*1 DPU. Analytical method development and validation for the simultaneous estimation of sofosbuvir and velpatasvir drug product by RP-HPLC method. 2017. https://zenodo.org/record/1036448#.XFar71wzayI. Accessed 3 Feb 2019 UR - https://zenodo.org/record/1036448#.XFar71wzayI ID - ref11 ER - TY - STD TI - Bandla J, Ganapaty S (2017) *Corresponding Stability indicating RP-HPLC method development and validation for the simultaneous determination of Sofosbuvir and Velpatasvir in tablet dosage forms. J Pharm Biol Res 7. http://www.ijpbr.in. Accessed 3 Feb 2019 UR - http://www.ijpbr.in ID - ref12 ER - TY - JOUR AU - Nalla, S. AU - Rao, J. V. PY - 2017 DA - 2017// TI - A stability indicating RP-HPLC method for simultaneous estimation of velpatasvir and sofosbuvir in combined tablet dosage forms JO - World J Pharm Pharmaceut Sci. VL - 6 UR - https://doi.org/10.20959/wjpps20179-10099 DO - 10.20959/wjpps20179-10099 ID - Nalla2017 ER - TY - STD TI - Kumaraswamy G, Pranay K, Rajkumar M, Lalitha R. Novel stabilty indicating rp-hplc method simultaneous determination of sofosbuvir and velpatasvir in bulk and combined tablet dosage forms. Innov Int J Med Pharm Sci. 2017;2(7). http://innovatpublisher.com/index.php/iijmps/article/view/62. Accessed 3 Feb 2019 UR - http://innovatpublisher.com/index.php/iijmps/article/view/62 ID - ref14 ER - TY - JOUR AU - El-Wekil, M. M. AU - Ali, H. R. H. AU - Marzouk, A. A. AU - Ali, R. PY - 2018 DA - 2018// TI - Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids JO - RSC Adv. VL - 8 UR - https://doi.org/10.1039/C7RA13719B DO - 10.1039/C7RA13719B ID - El-Wekil2018 ER - TY - JOUR AU - El-Gamal, R. M. AU - Abdel-Gawad, S. A. AU - Belal, F. F. AU - Moustapha, M. E. PY - 2018 DA - 2018// TI - Selective and sensitive spectrofluorimetric quantification of velpatasvir in presence of sofosbuvir. Application to their co-formulated tablet JO - RSC Adv. VL - 8 UR - https://doi.org/10.1039/C8RA06588H DO - 10.1039/C8RA06588H ID - El-Gamal2018 ER - TY - STD TI - Miller JN, Miller JC. Statistics and chemometrics for analytical chemistry. Sixth edition. http://www.pearsoned.co.uk/Miller. Accessed 3 Feb 2019 UR - http://www.pearsoned.co.uk/Miller ID - ref17 ER - TY - STD TI - International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline validation of analytical procedures: text and methodology Q2(R1). https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed 3 Feb 2019 UR - https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf ID - ref18 ER -